These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 17581301

  • 1. Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation.
    Cuneo KC, Fu A, Osusky K, Huamani J, Hallahan DE, Geng L.
    Anticancer Drugs; 2007 Aug; 18(7):793-800. PubMed ID: 17581301
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells.
    Zhang F, Zhang T, Teng ZH, Zhang R, Wang JB, Mei QB.
    Cancer Biol Ther; 2009 May; 8(9):823-31. PubMed ID: 19270532
    [Abstract] [Full Text] [Related]

  • 4. Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824.
    Atadja P, Gao L, Kwon P, Trogani N, Walker H, Hsu M, Yeleswarapu L, Chandramouli N, Perez L, Versace R, Wu A, Sambucetti L, Lassota P, Cohen D, Bair K, Wood A, Remiszewski S.
    Cancer Res; 2004 Jan 15; 64(2):689-95. PubMed ID: 14744786
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
    Toulany M, Mihatsch J, Holler M, Chaachouay H, Rodemann HP.
    Radiother Oncol; 2014 May 15; 111(2):228-36. PubMed ID: 24857596
    [Abstract] [Full Text] [Related]

  • 11. NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor.
    Yu L, Shang ZF, Hsu FM, Zhang Z, Tumati V, Lin YF, Chen BP, Saha D.
    Oncotarget; 2015 Feb 28; 6(6):3848-60. PubMed ID: 25714019
    [Abstract] [Full Text] [Related]

  • 12. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ, Wang X, Kachhap SK, Kato Y, Wei Y, Zhang L, Atadja P, Pili R.
    Cancer Res; 2004 Sep 15; 64(18):6626-34. PubMed ID: 15374977
    [Abstract] [Full Text] [Related]

  • 13. Oridonin Enhances Radiation-Induced Cell Death by Promoting DNA Damage in Non-Small Cell Lung Cancer Cells.
    Park H, Jeong YJ, Han NK, Kim JS, Lee HJ.
    Int J Mol Sci; 2018 Aug 13; 19(8):. PubMed ID: 30104472
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models.
    Albert JM, Cao C, Kim KW, Willey CD, Geng L, Xiao D, Wang H, Sandler A, Johnson DH, Colevas AD, Low J, Rothenberg ML, Lu B.
    Clin Cancer Res; 2007 May 15; 13(10):3033-42. PubMed ID: 17505006
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines.
    Balcer-Kubiczek EK, Attarpour M, Edelman MJ.
    Cancer Chemother Pharmacol; 2007 May 15; 59(6):781-7. PubMed ID: 16957930
    [Abstract] [Full Text] [Related]

  • 17. NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma.
    Catley L, Weisberg E, Tai YT, Atadja P, Remiszewski S, Hideshima T, Mitsiades N, Shringarpure R, LeBlanc R, Chauhan D, Munshi NC, Schlossman R, Richardson P, Griffin J, Anderson KC.
    Blood; 2003 Oct 01; 102(7):2615-22. PubMed ID: 12816865
    [Abstract] [Full Text] [Related]

  • 18. Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.
    Drummond DC, Marx C, Guo Z, Scott G, Noble C, Wang D, Pallavicini M, Kirpotin DB, Benz CC.
    Clin Cancer Res; 2005 May 01; 11(9):3392-401. PubMed ID: 15867240
    [Abstract] [Full Text] [Related]

  • 19. Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair.
    Toulany M, Kehlbach R, Florczak U, Sak A, Wang S, Chen J, Lobrich M, Rodemann HP.
    Mol Cancer Ther; 2008 Jul 01; 7(7):1772-81. PubMed ID: 18644989
    [Abstract] [Full Text] [Related]

  • 20. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
    Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL, Ismail S, Stevens C, Meyn RE.
    Clin Cancer Res; 2005 Jul 01; 11(13):4912-22. PubMed ID: 16000590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.